NCT05489211 2026-03-19
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
AstraZeneca
Phase 2 Recruiting
AstraZeneca
University of Michigan Rogel Cancer Center
Biosplice Therapeutics, Inc.
Peking University Third Hospital
Asan Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins